| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/07/2007 | US20070129355 G-protein-coupled chemoattractant receptor, expressed on T helper cells antagonists such as [4-(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)-5-pyrimidinyl]acetic acid;, used for the treatment of allergic diseases, inflammatory diseases, eosinophil- and basophil-related diseases |
| 06/07/2007 | US20070129346 Melanocortin receptor agonists |
| 06/07/2007 | US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia |
| 06/07/2007 | US20070128658 Fluorescent dyes, methods and uses thereof |
| 06/07/2007 | CA2636314A1 Arylmethylene urea derivative and use thereof |
| 06/07/2007 | CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2631232A1 Novel vinylogous acids derivatives |
| 06/07/2007 | CA2630314A1 1,5-substituted indol-2-yl amide derivatives |
| 06/07/2007 | CA2629964A1 2-aminobenzamide derivative |
| 06/07/2007 | CA2605073A1 Substituted indole compounds having nos inhibitory activity |
| 06/06/2007 | EP1792902A1 Processes for preparation of 5-(6-quinazolinyl)-furan-2-carbaldehydes |
| 06/06/2007 | EP1792613A2 Dicationic compounds which selectively recognize G-quadruplex DNA |
| 06/06/2007 | EP1791833A2 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 06/06/2007 | EP1791832A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 06/06/2007 | EP1791830A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 06/06/2007 | EP1791829A1 Heteroaroyl-substituted serine amides utilized as herbicides |
| 06/06/2007 | EP1791427A1 (hetero)cyclylcarboxamides for controlling pathogenic fungi |
| 06/06/2007 | EP1613313B1 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5]-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |
| 06/06/2007 | EP1496894A4 Angiogenesis inhibitors |
| 06/06/2007 | CN1976922A 4-amino-5-cyanopyrimidine derivatives |
| 06/06/2007 | CN1976907A Heterocyclic amide compound and use thereof as an MMP-13 inhibitor |
| 06/06/2007 | CN1976906A Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors |
| 06/06/2007 | CN1976905A Pyrimidine derivatives and methods of treatment related to the use thereof |
| 06/06/2007 | CN1976904A Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors |
| 06/06/2007 | CN1976706A Inhibition of FGFR3 and treatment of multiple myeloma |
| 06/06/2007 | CN1976705A 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia |
| 06/06/2007 | CN1976702A 3-aminocyclopentanecarboxamides as modulators of chemotactic factor receptors |
| 06/06/2007 | CN1976585A Substituted pyridazine carboxamides and derivatives thereof |
| 06/06/2007 | CN1319966C Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/06/2007 | CN1319962C 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
| 06/06/2007 | CN1319961C Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 06/06/2007 | CN1319959C Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors |
| 06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 06/05/2007 | US7226944 As antitumor agent |
| 06/05/2007 | US7226940 Such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 06/05/2007 | US7226933 3-[(1-benzyl-piperidin-4-yl)-(4-diethylcarbamoyl-phenyl)-amino]-benzamide used as opiod receptor agonists having improved pharmacokinetic, bioavailability, stability and/or lower toxicity; analgesisc; anxiolytic agents |
| 06/05/2007 | US7226930 Phosphodiesterase 4 inhibitors |
| 06/05/2007 | US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents |
| 06/05/2007 | US7226927 Administering 2-aryl-4- arylaminopyrimidine and analogs thereof, for therapy of disorder responsive to the induction of apoptosis in an animal suffering therefrom |
| 06/05/2007 | US7226918 DNA-PK inhibitors |
| 06/05/2007 | CA2262847C Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2 |
| 05/31/2007 | WO2007062417A1 Methods of preparing 2-imidazol-1-yl-4-methyl-6-pyrrolidin-2-yl-pyrimidine and 4-(1-alkylpyrrolidin-2-yl)-2-(1h-imidazol-1-yl)-6-methylpyrimidine derivatives |
| 05/31/2007 | WO2007062410A1 Imidazole derivatives as nitric oxide synthase dimerisation inhibitor |
| 05/31/2007 | WO2007062007A1 Beta-secretase modulators and methods of use |
| 05/31/2007 | WO2007061930A1 Beta-secretase modulators and methods of use |
| 05/31/2007 | WO2007061670A1 Beta-secretase modulators and methods of use |
| 05/31/2007 | WO2007061458A2 S1p receptor modulating compounds and use thereof |
| 05/31/2007 | WO2007061360A2 Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides |
| 05/31/2007 | WO2007061254A1 Genistein derivatives and anti-fungal composition containing the same |
| 05/31/2007 | WO2007060110A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
| 05/31/2007 | WO2007059610A1 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 05/31/2007 | WO2007042669A3 Derivatives of 4-amino-quinazoline, preparation method thereof and use of same in therapeutics |
| 05/31/2007 | WO2007042660A3 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof |
| 05/31/2007 | WO2007017687A3 Ep2 receptor agonists |
| 05/31/2007 | WO2007017289A3 Acyltryptophanols for fertility control |
| 05/31/2007 | WO2007014851A3 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 05/31/2007 | WO2006039215A3 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 05/31/2007 | US20070123718 Novel 4-amino-2(5H)-furanones |
| 05/31/2007 | US20070123582 Crystalline form of a drug |
| 05/31/2007 | US20070123576 Compounds inducing differentiation of myoblasts or muscle fibers into neuron cells, pharmaceutical composition including said compounds, a method for inducing neuron differentiation and a screening method for identifying additional compounds useful for inducing neuron differentiation |
| 05/31/2007 | US20070123575 Ep4 receptor antagonists |
| 05/31/2007 | US20070123570 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| 05/31/2007 | US20070123566 Isoflavone derivatives of tectoridin, the preparation thereof and the anti-virus medicines containing the same as an effective constituents |
| 05/31/2007 | US20070123553 Aryl imidazoles and their use as anti-cancer agents |
| 05/31/2007 | US20070123548 Pth agonists |
| 05/31/2007 | US20070123537 Quinazoline derivatives for the treatment of herpesviral infections |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | US20070123531 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 05/31/2007 | US20070123511 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| 05/31/2007 | US20070123475 podophyllotoxin analogs such as 4-beta-[(4''-benzamido)-amino]-4'-demethyl-epipodophyllotoxins and their 4'-ester derivatives used in the chemotherapy for various types of cancer |
| 05/31/2007 | US20070123421 Containing crystalline compounds which produce color when thermally converted to liquid or amorphous form time-independent |
| 05/31/2007 | US20070122444 Medical devices employing triazine compounds and compositions thereof |
| 05/31/2007 | CA2630699A1 Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators |
| 05/31/2007 | CA2630234A1 Thrombopoietin activity modulating compounds and methods |
| 05/31/2007 | CA2629554A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
| 05/31/2007 | CA2629527A1 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 05/31/2007 | CA2628527A1 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 05/31/2007 | CA2628146A1 Salts of inducible nitric oxide synthase dimerization inhibitors |
| 05/30/2007 | EP1790638A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity |
| 05/30/2007 | EP1790637A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 05/30/2007 | EP1790636A1 Piperidine derivatives and use thereof |
| 05/30/2007 | EP1789633A2 Benzamide compounds |
| 05/30/2007 | EP1789419A1 Gyrase inhibitors and uses thereof |
| 05/30/2007 | EP1789413A1 Vanilloid receptor ligands and their use in treatments |
| 05/30/2007 | EP1789412A1 Crystalline alfuzosin base |
| 05/30/2007 | EP1789399A1 Quinazolinone derivatives and their use as b-raf inhibitors |
| 05/30/2007 | EP1789390A2 Pyridyl inhibitors of hedgehog signalling |
| 05/30/2007 | EP1789389A1 Piperidine compound and process for preparing the same |
| 05/30/2007 | EP1789386A1 Substituted indole compounds, their preparation and use in medicaments |
| 05/30/2007 | EP1789036A2 5-ý3-(4-benzyloxyphenylthio)-fur-2-yl¨-imidazolidin-2, 4-dione and analogues as inhibitors of macrophage elastase |
| 05/30/2007 | EP1499577B1 2-(2,6-dichlorophenyl)-diarylimidazoles |
| 05/30/2007 | EP1476441B1 A method of eliminating sulfone analog in the synthesis of pyridine-benzimidazole sulfoxides |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1285655B1 Stabilized pharmaceutical compositions containing the calcium channel blocker azelnidipine |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | EP0819121B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 05/30/2007 | CN1972942A Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 05/30/2007 | CN1972934A 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 05/30/2007 | CN1972932A Compounds and methods for treating dyslipidemia |
| 05/30/2007 | CN1972926A Indole derivatives as histamine receptor antagonists |